Intuitive Surgical Stock News

Shares of Intuitive Surgical (ISRG) hit an all-time high Friday, a day after the medical device maker posted better-than-expected results on more use of its da Vinci minimally invasive surgical devices.

Major indexes faded late in Thursday's trading, with the Nasdaq Composite finishing up just .036%.

I reiterate a 'Sell' rating on Intuitive Surgical with a fair value of $350 per share due to its hefty valuation. The Da Vinci 5 robot rollout in mid-2025 is a major catalyst, with significant growth potential from innovative technology and positive surgeon feedback. Despite strong leadership and market position, ISRG's overvaluation and high WACC of 13% justify the 'Sell' rating.

Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q3 2024 Earnings Conference Call October 17, 2024 4:30 PM ET Company Participants Brandon Lamb - Investor Relations Gary Guthart - Chief Executive Officer Dave Rosa - President Jamie Samath - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan David Roman - Goldman Sach...

The robotic surgery leader reported strong Q3 results.

Medical device maker Intuitive Surgical beat Wall Street estimates for third-quarter profit on Thursday, helped by strong demand for its surgical robots used in minimally invasive procedures, sending shares up 6% in extended trading.

Shares of Intuitive Surgical Inc. jumped after hours on Thursday after the company reported third-quarter results that beat Wall Street's expectations, helped by wider adoption of its robotic-surgery equipment.

Intuitive Surgical stock is flirting with its 50-day line as the robotic surgery behemoth approaches its third-quarter report late Thursday.